-

North American Walking Aids Market Insights & Forecast, 2019-2025 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "North America Walking Aids Market, by Type, by Rollators Type, by Country, Industry Analysis and Forecast, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.

The North America Walking Aids Market is expected to witness market growth of 5.1% CAGR during the forecast period (2019-2025).

According to figures released by the World Bank in 2019, about 15% of the world's population and 20 to 25% of the aging population are presently suffering from some form of disability and are anticipated to increase in the future. Enhanced accessibility and increased social acceptance are also described as the driving factors for this market.

In addition, the presence of disabled people in the workforce by walking aids and an increase in the number of obese people is also assumed to boost the market demand for walking aids. There is an increasing demand for more efficient, sustainable, and cost-effective walking aids in the market. Nevertheless, the emergence of a demand for refurbished products and price pressures can be a significant restraining factor in the growth of the overall market.

The walking aid market is set to enlarge even further over the estimation years. Advances in medical care, as well as increased care for people with disabilities in general, can also explain the continued rise in coverage. Enhanced safety from walking aids can also be associated with the growth of the sector.

Until very recently, there were very little efforts to prevent people with disabilities from selling walking aids. It meant that many individuals had purchased aids that were not fit for purpose or that were unsuitable to the needs of the person. Nevertheless, the government has intervened and, following an official investigation by the Fair Trading Office, the market is now heavily regulated.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Invacare Corporation, Benmor Medical Ltd., Human Care AB, Briggs Healthcare Corporation, Compass Health Brands Corporation (Carex Health Brands), Eurovema Mobility AB, Topro Industrie AS, Evolution Technology, Inc., GF Health Products, Inc., and Karman Healthcare.

Key Topics Covered

Chapter 1. Market Scope & Methodology

1.1 Market Definition

1.2 Objectives

1.3 Market Scope

1.4 Segmentation

1.4.1 North America Walking Aids Market, by Type

1.4.2 North America Walking Aids Market, by Rollators Type

1.4.3 North America Walking Aids Market, by Country

1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction

2.1.1 Overview

2.1.2 Market Composition and Scenario

2.2 Key Factors Impacting the Market

2.2.1 Market Drivers

2.2.2 Market Restraints

Chapter 3. North America Walking Aids Market by Type

3.1 North America Rollators Market by Country

3.1.1 North America Walking Aids Market by Rollators Type

3.1.1.1 North America Premium Market by Country

3.1.1.2 North America Low cost Market by Country

3.2 North America Walkers Market by Country

3.3 North America Other Walking Aids Market by Country

Chapter 4. North America Walking Aids Market by Country

4.1 US Walking Aids Market

4.1.1 US Walking Aids Market by Type

4.1.1.1 US Walking Aids Market by Rollators Type

4.2 Canada Walking Aids Market

4.3 Mexico Walking Aids Market

4.4 Rest of North America Walking Aids Market

Chapter 5. Company Profiles

5.1 Invacare Corporation

5.1.1 Company Overview

5.1.2 Financial Analysis

5.1.3 Segmental and Regional Analysis

5.1.4 Research & Development Expense

5.2 Benmor Medical Ltd.

5.3 Human Care AB

5.4 Briggs Healthcare Corporation

5.5 Compass Health Brands Corporation (Carex Health Brands)

5.6 Eurovema Mobility AB

5.7 Topro Industri AS

5.8 Evolution Technology, Inc.

5.9 GF Health Products, Inc.

5.1 Karman Healthcare

For more information about this report visit https://www.researchandmarkets.com/r/hrzgnz

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Malaysia Defense Industry Report 2025: $4.8 Billion Allocation in 2025 Reflects 6.0% CAGR Growth Momentum - Forecast to 2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Malaysia Defense Market - Size and Trends, Budget Allocation, Regulations, Key Acquisitions, Competitive Landscape and Forecast, 2025-2030" report has been added to ResearchAndMarkets.com's offering. The report provides the market size forecast and the projected growth rate for the next five years. The report covers industry analysis including the key market drivers, emerging technology trends, and major challenges faced by market participants. It also offers insig...

France Defense Industry Report 2025: Defense Expenditure Driven by Domestic Modernization Programs, Russia and the Invasion of Ukraine and NATO Alliance - Forecast to 2030 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "France Defense Market - Size and trends, budget allocation, regulations, key acquisitions, competitive landscape and forecast, 2025-2030" report has been added to ResearchAndMarkets.com's offering. The report provides the market size forecast and the projected growth rate for the next five years. The report covers industry analysis including the key market drivers, emerging technology trends, and major challenges faced by market participants. It also offers insight...

$43.4 Bn Orphan Drugs Service Markets 2019-2024, 2024-2029F, 2034F - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Orphan Drugs Service Market Report 2025" has been added to ResearchAndMarkets.com's offering. The global orphan drugs service market is witnessing unprecedented growth, reflecting the increasing focus on rare diseases, investment in biopharmaceutical research, and enhanced collaborations between healthcare providers and researchers. From $37.05 billion in 2024, the market is projected to soar to $43.4 billion by 2025, with a robust CAGR of 17.1%. Growth drivers inc...
Back to Newsroom